Results 111 to 120 of about 1,399 (158)

Inhibition of Ejaculation Due to Epsilon Aminocaproic Acid

New England Journal of Medicine, 1978
L M Aledort
exaly   +3 more sources

Contact dermatitis from epsilon-aminocaproic acid

Contact Dermatitis, 1993
M, Tanaka, H, Niizeki, S, Miyakawa
exaly   +3 more sources

Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid

Annals of Pharmacotherapy, 1997
OBJECTIVE: To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA). CASE SUMMARY: A 33-year-old female patient with chronic granulocytic leukemia was treated with epsilon-ACA for approximately 3.5 ...
B D, Seymour, M, Rubinger
openaire   +2 more sources

Thrombosis with Epsilon Aminocaproic Acid Therapy

American Journal of Clinical Pathology, 1971
A patient with postoperative bleeding was treated with epsilon aminocaproic acid (EACA). Subsequent coagulation studies supported the diagnosis of intravascular coagulation and the patient subsequently developed renal failure due to glomerular thromboses.
H R, Gralnick, P, Greipp
openaire   +2 more sources

Epsilon-Aminocaproic Acid Myopathy

European Neurology, 2008
A case of acute necrotic myopathy due to epsilon-aminocaproic acid (EACA) is described and compared with similar cases in the literature. This myopathy has only been noted after prolonged administration of the drug. The pathogenesis of this necrotic myopathy remains unclear, but our findings did not support a muscular vasculitis or an autoimmune ...
J.A.L. Vanneste, G.K. van Wijngaarden
openaire   +1 more source

Epsilon Aminocaproic Acid — A Dangerous Weapon

New England Journal of Medicine, 1969
Of the body's defenses against injury, the proteolytic activity of plasmin, an enzyme that can evolve in plasma from an inert precursor, plasminogen, is most intriguing. Clinical attention has been centered upon the digestion of fibrin by plasmin, but this enzyme also digests other clotting factors, converts the first component of complement to its ...
openaire   +2 more sources

Effect of probenecid on the kinetics of epsilon-aminocaproic acid

Clinical Pharmacology and Therapeutics, 1980
Healthy male subjects received, 1 wk apart, single oral doses of epsilon-aminocaproic acid (EACA) 100 mg/kg alone, EACA within probenecid (0.5 gm), or EACA 2 hr after 2.0 gm probenecid. Probenecid (2.0 gm) reduced the 8-hr urinary clearance and recovery of EACA by 50% without affecting plasma kinetics.
B H, Dvorchik, K L, Katlic, A H, Hayes, M E, Eyster   +3 more
openaire   +2 more sources

Epsilon-Aminocaproic Acid for Synovectomy in Haemophilic Patients

Acta Haematologica, 2009
The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of
E, Storti, E, Ascari, R, Turpini, E, Molinari, G, Gamba, A, Pettene   +5 more
openaire   +2 more sources

Myopathy induced by epsilon-aminocaproic acid

Journal of Neurosurgery, 1982
✓ The authors present a case of proximal myopathy secondary to epsilon-aminocaproic acid (EACA) administration. This well recognized entity does not occur immediately after institution of therapy, but follows a delay of several days and a cumulative dose.
J A, Brown, R L, Wollmann, S, Mullan
openaire   +2 more sources

HAEMORRHAGIC CYSTITIS TREATED WITH EPSILON–AMINOCAPROIC ACID

Medical Journal of Australia, 1980
A life-threatening haemorrhagic cystitis, which occurred in a patient with metastatic prostatic carcinoma, was controlled with epsilon-aminocaproic acid (EACA) after conventional approaches to treatment failed. EACA administration was both systemic and intravesical, and control of bleeding occurred within 24 hours after initiation of treatment.
R S, Aroney, D N, Dalley, J A, Levi
openaire   +2 more sources